欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1800/001
药品名称MOVPREP
活性成分
    • macrogol 100.0 g
    • Potassium chloride 1.01 g
    • Sodium sulfate 7.5 g
    • Sodium chloride 2.69 g
剂型Powder for oral solution
上市许可持有人Norgine BV
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 20142/0005 - 0041
    • Germany (DE)
      Moviprep, Pulver zur Herstellung einer Lösung zum Einnehmen
    • Denmark (DK)
      Moviprep
    • Belgium (BE)
    • Netherlands (NL)
      Moviprep
    • Ireland (IE)
    • Austria (AT)
      MOVIPREP Pulver zur Herstellung einer Lösung zum Einnehmen
    • Iceland (IS)
    • France (FR)
    • Norway (NO)
    • Spain (ES)
    • Poland (PL)
      MOVIPREP
    • Italy (IT)
    • Luxembourg (LU)
    • Lithuania (LT)
      Moviprep milteliai geriamajam tirpalui
    • Portugal (PT)
    • Estonia (EE)
    • Finland (FI)
    • Bulgaria (BG)
      Moviprep
    • Czechia (CZ)
      MOVIPREP® Prášek pro přípravu perorálního roztoku
    • Romania (RO)
      Moviprep pulbere pentru solutie orala
    • Slovakia (SK)
      MOVIPREP
    • Slovenia (SI)
    • Malta (MT)
    • Latvia (LV)
许可日期2008/04/05
最近更新日期2024/10/18
药物ATC编码
    • A06AD13 sodium sulfate
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase